Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.41M 2.09M 1.95M 1.79M 229M 3.42M 22.89M 8.99M 115M 9.06M 8.86M 380M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.12M 2.7M 2.52M 2.31M 296M 4.42M 29.56M 11.6M 148M 11.7M 11.45M 491M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2004-06-16 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2004-06-16 | |
J. Lievonen
CHM | Chairman | - | 2021-07-04 |
Jeffrey Shon
BRD | Director/Board Member | - | 2021-07-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.4M | |
| +0.90% | -2.33% | +0.68% | +13.87% | 48B | |
| +1.98% | +9.05% | +413.94% | +532.17% | 41.13B | |
| +3.44% | -4.65% | +28.34% | +8.81% | 37.56B | |
| +1.40% | +0.10% | +6.61% | +61.93% | 35.91B | |
| +2.42% | +5.72% | +12.38% | +44.79% | 29.86B | |
| -0.16% | -3.11% | - | - | 16.12B | |
| +2.20% | +0.48% | +34.71% | +127.15% | 16.05B | |
| +1.25% | +1.52% | +4.62% | +18.26% | 13.76B | |
| +4.25% | -8.23% | -1.49% | -35.46% | 12.1B | |
| Average | -1.69% | -0.75% | +62.47% | +96.44% | 27.83B | |
| Weighted average by Cap. | +1.91% | -0.00% | +82.48% | +120.78% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.28M -1.11M -1.04M -954K -122M -1.82M -12.19M -4.78M -61.13M -4.83M -4.72M -202M | 5M 3.57M 3.09M 2.88M 2.65M 339M 5.05M 33.83M 13.28M 170M 13.39M 13.1M 562M |
| Net Debt | 795K 567K 491K 458K 421K 53.92M 804K 5.38M 2.11M 26.98M 2.13M 2.08M 89.35M | 986K 703K 609K 568K 522K 66.86M 997K 6.67M 2.62M 33.45M 2.64M 2.58M 111M |
Employees
-
